Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Nature Medicine|October 25, 2011
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesYoko S DeRose, Guoying Wang, Yi-Chun Lin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 14, 2018
Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15Michael J Madsen, Stacey Knight, Carol Sweeney, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
A precision oncology-focused deep learning framework for personalized selection of cancer therapyCasey Sederman, Chieh-Hsiang Yang, Emilio Cortes-Sanchez, et al.
Oncogene|June 9, 2021
PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancerThu H Truong, Elizabeth A Benner, Kyla M Hagen, et al.
JCO Precision Oncology|July 29, 2024
TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast CancerChristos Vaklavas, Cindy B Matsen, Zhengtao Chu, et al.
Cancer Cell|October 21, 2022
A path to translation: How 3D patient tumor avatars enable next generation precision oncologyShree Bose, Margarida Barroso, Milan G Chheda, et al.
Nature Medicine|March 29, 2019
Publisher Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancersConan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, et al.
Nature Medicine|March 6, 2019
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancersConan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, et al.
Iscience|January 9, 2023
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approachVarduhi Petrosyan, Lacey E Dobrolecki, Lillian Thistlethwaite, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy ResponsesJonathan T Lei, Lacey E Dobrolecki, Chen Huang, et al.
Pageof 6